These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Xeris Biopharma Holdings, Inc. , a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, ...

and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome.

Transient paralysis indicates hyperkalemic periodic paralysis, and fluctuating myotonia indicates potassium-aggravating myotonia. 10,11 Electrophysiological studies can also provide information ...

Dr. Anh Nguyen brings significant experience to his role as CMO, having led the development of first-in-class therapies ...

Medically reviewed by Daniel Combs, MD More than 50 million Americans have a sleep disorder. Regularly having trouble ...

Good data not only helps formulate strategy, but also reduces the risk of policy paralysis. Over the last 75 years, data ...

The Ethiopian government launched a nationwide polio vaccination campaign on Wednesday, targeting more than 13.8 million ...

Good data not only helps formulate strategy, but also reduces the risk of policy paralysis ... Recent evidence from the Periodic Labour Force Survey (PLFS), which is being conducted annually ...